Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 542

1.

The cleistogamy of the superwoman1-cleistogamy1 mutation is sensitive to low temperatures during the lodicule-forming stage.

Ohmori S, Koike S, Hayashi T, Yamaguchi T, Kuroki M, Yoshida H.

Breed Sci. 2018 Sep;68(4):432-441. doi: 10.1270/jsbbs.18028. Epub 2018 Aug 28.

2.

Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration.

Mashima E, Sawada Y, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S, Okada E, Nakamura M.

Eur J Dermatol. 2018 Aug 1;28(4):539-540. doi: 10.1684/ejd.2018.3327. No abstract available.

PMID:
30325327
3.

Profile fluctuation of peripheral blood in advanced melanoma patients treated with nivolumab.

Saito R, Sawada Y, Saito-Sasaki N, Yamamoto K, Yoshioka H, Ohmori S, Yoshioka M, Okada E, Nakamura M.

J Dermatol. 2018 Dec;45(12):1452-1455. doi: 10.1111/1346-8138.14643. Epub 2018 Sep 11.

PMID:
30204257
4.

Carapanosins D-F from the Seeds of Andiroba (Carapa guianensis, Meliaceae) and Their Effects on LPS-Activated NO Production.

Inoue T, Ohmori S, Kikuchi T, Yamada T, Tanaka R.

Molecules. 2018 Jul 19;23(7). pii: E1778. doi: 10.3390/molecules23071778.

5.

A Specific Probe Substrate for Evaluation of CYP4A11 Activity in Human Tissue Microsomes and a Highly Selective CYP4A11 Inhibitor: Luciferin-4A and Epalrestat.

Yamaori S, Araki N, Shionoiri M, Ikehata K, Kamijo S, Ohmori S, Watanabe K.

J Pharmacol Exp Ther. 2018 Sep;366(3):446-457. doi: 10.1124/jpet.118.249557. Epub 2018 Jul 5.

PMID:
29976573
6.

Alopecia Areata-like Hair Loss Accompanying Toxic Epidermal Necrolysis.

Mashima E, Sawada Y, Inoue A, Saito-Sasaki N, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Acta Derm Venereol. 2018 Oct 10;98(9):906-907. doi: 10.2340/00015555-2982. No abstract available.

7.

[Evaluation of an Evidence-based Medicine Educational Program for Pharmacists and Pharmacy Students].

Shimizu T, Ueda M, Toyoyama M, Ohmori S, Takagaki N.

Yakugaku Zasshi. 2018;138(5):655-666. doi: 10.1248/yakushi.17-00190-5. Japanese.

8.

Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression.

Saito-Sasaki N, Sawada Y, Mashima E, Yamaguchi T, Ohmori S, Yoshioka H, Haruyama S, Okada E, Nakamura M.

Sci Rep. 2018 Apr 3;8(1):5522. doi: 10.1038/s41598-018-23623-9.

9.

Climber's knuckle excoriation.

Ohmori S, Sawada Y, Nakamura M.

J Dermatol. 2018 Sep;45(9):e264-e265. doi: 10.1111/1346-8138.14301. Epub 2018 Mar 23. No abstract available.

PMID:
29572907
10.

A novel base pair deletion in the TRPS1 gene in a Japanese patient with trichorhinophalangeal syndrome.

Saito R, Yamaguchi T, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Okada E, Nakamura M.

Eur J Dermatol. 2018 Feb 1;28(1):107-108. doi: 10.1684/ejd.2018.3253. No abstract available.

PMID:
29521629
11.

A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides.

Mashima E, Sawada Y, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Clin Immunol. 2018 Aug;193:121-122. doi: 10.1016/j.clim.2018.01.005. Epub 2018 Jan 31. No abstract available.

PMID:
29391198
12.

Sporadic breast metastasis derived from renal cell carcinoma: A case report.

Ikarashi D, Ishida K, Kashiwaba M, Kato Y, Shiomi E, Takayama M, Komatsu H, Takata R, Ohmori S, Sugai T, Obara W.

Urol Case Rep. 2017 Dec 5;16:126-128. doi: 10.1016/j.eucr.2017.11.032. eCollection 2018 Jan. No abstract available.

13.

A novel base pair deletion in the TRPS1 gene in a Japanese patient with trichorhinophalangeal syndrome.

Saito R, Yamaguchi T, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Okada E, Nakamura M.

Eur J Dermatol. 2017 Nov 27. doi: 10.1684/ejd.2017.3172. [Epub ahead of print] No abstract available.

PMID:
29180318
14.

Evaluation of an Evidence-based Medicine Educational Program for Pharmacists and Pharmacy Students.

Shimizu T, Ueda M, Toyoyama M, Ohmori S, Takagaki N.

Yakugaku Zasshi. 2017;137(8):987-998. doi: 10.1248/yakushi.16-00179. Japanese.

15.

Stevens-Johnson Syndrome After Influenza Vaccine Injection.

Oda T, Sawada Y, Okada E, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Nakamura M.

J Investig Allergol Clin Immunol. 2017;27(4):274-275. doi: 10.18176/jiaci.0169. No abstract available.

16.

Drug eruption caused by memantine.

Saito R, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Ann Allergy Asthma Immunol. 2017 Jul;119(1):89-90. doi: 10.1016/j.anai.2017.05.005. No abstract available.

PMID:
28668245
17.

Endometriosis in the setting of Muckle-Wells syndrome treated with an IL-1β antagonist.

Sasaki-Saito N, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Eur J Dermatol. 2017 Aug 1;27(4):442-443. doi: 10.1684/ejd.2017.3052. No abstract available.

PMID:
28508753
18.

Eosinophilic Cellulitis Possibly Due to Mosquito Bite With High IL-5 Production.

Mashima E, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

J Investig Allergol Clin Immunol. 2017;27(2):149-150. doi: 10.18176/jiaci.0142. No abstract available.

19.

Drug Eruption Caused by Rosuvastatin.

Oda T, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

J Investig Allergol Clin Immunol. 2017;27(2):140-141. doi: 10.18176/jiaci.0136. No abstract available.

20.

Carapanosins A-C from Seeds of Andiroba (Carapa guianensis, Meliaceae) and Their Effects on LPS-Activated NO Production.

Higuchi K, Miyake T, Ohmori S, Tani Y, Minoura K, Kikuchi T, Yamada T, Tanaka R.

Molecules. 2017 Mar 22;22(3). pii: E502. doi: 10.3390/molecules22030502.

21.

Hypopituitarism and hypothyroidism following atrioventricular block during nivolumab treatment.

Oda T, Sawada Y, Okada E, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Nakamura M.

J Dermatol. 2017 Jun;44(6):e144-e145. doi: 10.1111/1346-8138.13797. Epub 2017 Mar 11. No abstract available.

PMID:
28295551
22.

Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23.

Oda T, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Okada E, Nakamura M.

J Investig Allergol Clin Immunol. 2017;27(1):63-64. doi: 10.18176/jiaci.0116. No abstract available.

23.

Acute edema/cutaneous distension syndrome due to POEMS syndrome.

Hitaka T, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

J Dermatol. 2017 Jun;44(6):e132-e133. doi: 10.1111/1346-8138.13774. Epub 2017 Feb 13. No abstract available.

PMID:
28191655
24.

Maculopapular eruption caused by doripenem.

Shibata M, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Eur J Dermatol. 2017 Apr 1;27(2):197-198. doi: 10.1684/ejd.2016.2945. No abstract available.

PMID:
28007670
25.

Maculopapular type drug eruption caused by fosphenytoin.

Saito-Sasaki N, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Eur J Dermatol. 2016 Oct 1;26(5):502-503. No abstract available.

PMID:
27545069
26.

Photosensitivity due to tocilizumab presenting with erythema multiforme-like lesions.

Hamada K, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Eur J Dermatol. 2016 Oct 1;26(5):503-504. No abstract available.

PMID:
27346710
27.

Annular erythematous eruption with a high response to mosquito bite.

Mashima E, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

J Dermatol. 2016 Nov;43(11):1378-1380. doi: 10.1111/1346-8138.13393. Epub 2016 Mar 30. No abstract available.

PMID:
27027741
28.

Lichenoid drug eruption caused by adalimumab: a case report and literature review.

Inoue A, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Eur J Dermatol. 2017 Feb 1;27(1):69-70. doi: 10.1684/ejd.2016.2898. Review. No abstract available.

PMID:
27777187
29.

A possible role of IL-23-producing cells in a patient with psoriasiform drug eruption due to tazobactam and piperacillin hydrate: a case study and literature review.

Saito-Sasaki N, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Okada E, Nakamura M.

Eur J Dermatol. 2017 Feb 1;27(1):88-89. doi: 10.1684/ejd.2016.2883. Review. No abstract available.

PMID:
27748262
30.

Drug eruption caused by secukinumab.

Shibata M, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Eur J Dermatol. 2017 Feb 1;27(1):67-68. doi: 10.1684/ejd.2016.2900. No abstract available.

PMID:
27748259
31.

A possible role of IL-23/IL-17 axis in patients with lupus miliaris disseminatus faciei.

Saito-Sasaki N, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Clin Immunol. 2016 Oct;171:36-37. doi: 10.1016/j.clim.2016.08.007. Epub 2016 Aug 8. No abstract available.

PMID:
27515793
32.

Anaphylactoid purpura triggered by cellulitis as a favorable prognosis: case report and literature review.

Saito-Sasaki N, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Springerplus. 2016 Jul 19;5(1):1112. doi: 10.1186/s40064-016-2792-2. eCollection 2016.

33.

Calciphylaxis following acute renal injury: a case and literature review.

Oda T, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Okada E, Nakamura M.

Springerplus. 2016 Jul 11;5(1):1043. doi: 10.1186/s40064-016-2740-1. eCollection 2016.

34.

A possible pathogenetic role of IL-23/IL-17 axis in rheumatoid nodules in patients with rheumatoid arthritis.

Saito-Sasaki N, Sawada Y, Omoto D, Ohmori S, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Clin Immunol. 2016 Sep;170:20-1. doi: 10.1016/j.clim.2016.07.002. Epub 2016 Jul 4. No abstract available.

PMID:
27388654
35.

The superwoman1-cleistogamy2 mutant is a novel resource for gene containment in rice.

Lombardo F, Kuroki M, Yao SG, Shimizu H, Ikegaya T, Kimizu M, Ohmori S, Akiyama T, Hayashi T, Yamaguchi T, Koike S, Yatou O, Yoshida H.

Plant Biotechnol J. 2017 Jan;15(1):97-106. doi: 10.1111/pbi.12594. Epub 2016 Jul 18.

36.

Fixed drug eruption-like macules caused by febuxostat.

Oda T, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Eur J Dermatol. 2016 Aug 1;26(4):412-3. doi: 10.1684/ejd.2016.2796. No abstract available.

PMID:
27211520
37.

Erythema papulosa semicircularis recidivans associated with primary pancreas B cell lymphoma.

Inoue A, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Eur J Dermatol. 2016 Jun 1;26(3):306-7. doi: 10.1684/ejd.2016.2749. No abstract available.

PMID:
27192933
38.

Dome-shaped metastatic lesion on the scalp from a uterine smooth muscle tumor of uncertain malignant potential (STUMP).

Sakuragi Y, Inoue A, Mashima E, Yamaguchi T, Sasaki N, Hara Y, Omoto D, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Nishio D, Nakamura M.

Eur J Dermatol. 2016 Apr 1;26(2):193-4. doi: 10.1684/ejd.2016.2790. No abstract available.

PMID:
27086706
39.

Lichenoid Drug Eruption Caused by Limaprost Alfadex.

Inoue A, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Acta Derm Venereol. 2016 Nov 2;96(7):997-998. doi: 10.2340/00015555-2435. No abstract available.

40.

Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti.

Saito-Ito A, Kawai A, Ohmori S, Nagano-Fujii M.

Parasitol Int. 2016 Oct;65(5 Pt B):526-531. doi: 10.1016/j.parint.2016.03.007. Epub 2016 Mar 24.

PMID:
27033029
41.

Maculopapular type drug eruption caused by pregabalin: A case and literature review.

Inoue A, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Allergol Int. 2016 Jul;65(3):351-2. doi: 10.1016/j.alit.2016.02.006. Epub 2016 Mar 11. No abstract available.

42.

Development of absolute quantification method for genotype-specific Babesia microti using real-time PCR and practical experimental tips of real-time PCR.

Ohmori S, Nagano-Fujii M, Saito-Ito A.

Parasitol Int. 2016 Oct;65(5 Pt B):567-571. doi: 10.1016/j.parint.2016.03.003. Epub 2016 Mar 10.

PMID:
26972181
43.

Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins.

Yano K, Otsuka K, Kato Y, Kawabata H, Ohmori S, Arakawa H, Ogihara T.

J Pharm Pharmacol. 2016 Mar;68(3):361-7. doi: 10.1111/jphp.12525. Epub 2016 Feb 17.

PMID:
26888084
44.

Maculopapular type drug eruption caused by silodosin.

Inoue A, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nisio D, Nakamura M.

Allergol Int. 2016 Apr;65(2):219-220. doi: 10.1016/j.alit.2015.11.008. Epub 2016 Jan 21. No abstract available.

45.

Multiple fixed drug eruption caused by ropinirole in a patient with Parkinson's disease.

Sasaki-Saito N, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Allergol Int. 2016 Apr;65(2):221-222. doi: 10.1016/j.alit.2015.12.003. Epub 2016 Jan 17. No abstract available.

46.

Acute edema/cutaneous distension syndrome representing as eczéma craquelé-like change: A case and published work review.

Yamada S, Sawada Y, Ohmori S, Omoto D, Haruyama S, Kubo R, Yoshioka M, Nishio D, Nakamura M.

J Dermatol. 2016 Jun;43(6):709-10. doi: 10.1111/1346-8138.13267. Epub 2016 Jan 18. Review. No abstract available.

PMID:
26775716
47.

Photoallergic Drug Eruption Caused by Certolizumab Pegol.

Inoue A, Sawada Y, Ohmori S, Omoto D, Haruyama S, Kabashima-Kubo R, Yoshioka M, Nisio D, Nakamura M.

Acta Derm Venereol. 2016 Jun 15;96(5):710-1. doi: 10.2340/00015555-2334. No abstract available.

48.

First case of acute generalized exanthematous pustulosis caused by pitavastatin: possible pathogenetic role of IL-36.

Saito-Sasaki N, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Eur J Dermatol. 2016 Jan-Feb;26(1):106-7. doi: 10.1684/ejd.2015.2694. No abstract available.

PMID:
26679546
49.

Increased circulating Th17 cell in a patient with tinea capitis caused by Microsporum canis.

Sakuragi Y, Sawada Y, Hara Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M.

Allergol Int. 2016 Apr;65(2):215-216. doi: 10.1016/j.alit.2015.10.003. Epub 2015 Nov 21. No abstract available.

50.

Excessive hair growth around local β-interferon injection sites for malignant melanoma.

Inoue A, Yamaguchi T, Saito N, Omoto D, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Nishio D, Nakamura M.

J Dermatol. 2016 Apr;43(4):453-4. doi: 10.1111/1346-8138.13224. Epub 2015 Dec 12. No abstract available.

PMID:
26662941

Supplemental Content

Loading ...
Support Center